Advantage Alpha Capital Partners’s Dynavax Technologies DVAX Stock Holding History

Advantage Alpha Capital Partners’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25,892	Closed	-$257K	–	36
2025 Q3	$257K	Sell	25,892 -5,266	-17%	-$54.8K	0.08%	121
2025 Q2	$309K	Sell	31,158 -7,285	-19%	-$76.8K	0.08%	109
2025 Q1	$499K	Buy	38,443 +13,345	+53%	+$177K	0.12%	98
2024 Q4	$321K	Sell	25,098 -21,053	-46%	-$255K	0.08%	139
2024 Q3	$514K	Sell	46,151 -34,099	-42%	-$376K	0.12%	115
2024 Q2	$901K	Sell	80,250 -8,433	-10%	-$98.2K	0.2%	87
2024 Q1	$1.1M	Sell	88,683 -404	-0.5%	-$5.27K	0.21%	97
2023 Q4	$1.25M	Buy	+89,087	New	+$1.24M	0.24%	97

Other funds holding DVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Advantage Alpha Capital Partners's DVAX Position: Q4 2025 in Review

Advantage Alpha Capital Partners sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 25,892 shares — an estimated $257K sold.

Advantage Alpha Capital Partners first reported a position in DVAX in Q4 2023 and held it in 8 quarters. The position peaked at $1.25M in Q4 2023. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

Advantage Alpha Capital Partners reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
Advantage Alpha Capital Partners sold 25,892 Dynavax Technologies shares in Q4 2025, an estimated $257K.
Advantage Alpha Capital Partners first reported a position in Dynavax Technologies in Q4 2023 and held it in 8 quarters.
Advantage Alpha Capital Partners's Dynavax Technologies position peaked at $1.25M in Q4 2023.
266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2025.